EP1599189A4 - Formulation a liberation commandee renfermant une substance hydrophobe comme agent de liberation soutenue - Google Patents

Formulation a liberation commandee renfermant une substance hydrophobe comme agent de liberation soutenue

Info

Publication number: EP1599189A4
Authority: EP; European Patent Office
Prior art keywords: hydrophobic material; formulation containing; release agent; sustained release; release formulation
Prior art date: 2003-03-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP03816186A

Other languages

German (de)

English (en)

Other versions

EP1599189A1 (fr

Inventor

Mulye Nirmal

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Nostrum Pharmaceuticals Inc

Original Assignee

Nostrum Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-04

Filing date

2003-03-04

Publication date

2009-07-01

2003-03-04 Application filed by Nostrum Pharmaceuticals Inc filed Critical Nostrum Pharmaceuticals Inc

2005-11-30 Publication of EP1599189A1 publication Critical patent/EP1599189A1/fr

2009-07-01 Publication of EP1599189A4 publication Critical patent/EP1599189A4/fr

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Biophysics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP03816186A 2003-03-04 2003-03-04 Formulation a liberation commandee renfermant une substance hydrophobe comme agent de liberation soutenue Withdrawn EP1599189A4 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2003/006505 WO2004078164A1 (fr)	2003-03-04	2003-03-04	Formulation a liberation commandee renfermant une substance hydrophobe comme agent de liberation soutenue

Publications (2)

Publication Number	Publication Date
EP1599189A1 EP1599189A1 (fr)	2005-11-30
EP1599189A4 true EP1599189A4 (fr)	2009-07-01

Family

ID=32961106

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP03816186A Withdrawn EP1599189A4 (fr)	2003-03-04	2003-03-04	Formulation a liberation commandee renfermant une substance hydrophobe comme agent de liberation soutenue

Country Status (8)

Country	Link
EP (1)	EP1599189A4 (fr)
JP (1)	JP2006514672A (fr)
AU (1)	AU2003225649C1 (fr)
BR (1)	BR0318167A (fr)
CA (1)	CA2518442A1 (fr)
MX (1)	MXPA05009469A (fr)
NZ (1)	NZ542176A (fr)
WO (1)	WO2004078164A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005049001A1 (de) *	2005-10-11	2007-04-12	Basf Ag	Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen
CN104288844A (zh) *	2007-10-18	2015-01-21	杜雷科特公司	具有可控堆积密度的可生物降解植入物
CN105456217A (zh) *	2014-08-27	2016-04-06	捷思英达医药技术（上海）有限公司	一种双丙戊酸钠缓释剂组合物及其制备方法
US20170273923A1 (en) *	2016-03-23	2017-09-28	Sun Pharmaceutical Industries Ltd.	Method of administering divalproex

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3343253A1 (de) *	1983-08-11	1985-02-21	Neill Bailey San Antonio Tex. Walsdorf	Fluorid-tablette mit verzoegerter wirkstoff-freigabe und verfahren zu ihrer herstellung
WO1997032584A1 (fr) *	1996-03-04	1997-09-12	Synthelabo	Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine
WO2000001416A1 (fr) *	1998-07-07	2000-01-13	Yissum Research Developing Company Of The Hebrew University Of Jerusalem	Compositions pharmaceutiques contenant des cires a bas point de fusion
US6033685A (en) *	1997-01-10	2000-03-07	Abbott Laboratories	Tablet for the controlled release of active agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL109770A0 (en) *	1993-05-29	1994-11-28	Smithkline Beecham Corp	Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
DE19847618A1 (de) *	1998-10-15	2000-04-20	Basf Ag	Verfahren zur Herstellung von festen Dosierungsformen
US6413546B1 (en) *	1999-03-18	2002-07-02	Indena, S.P.A.	Tablets incorporating isoflavone plant extracts and methods of manufacturing them
AR025609A1 (es) *	1999-09-13	2002-12-04	Hoffmann La Roche	Formulaciones lipidas solidas

2003
- 2003-03-04 AU AU2003225649A patent/AU2003225649C1/en not_active Ceased
- 2003-03-04 BR BRPI0318167-7A patent/BR0318167A/pt not_active IP Right Cessation
- 2003-03-04 EP EP03816186A patent/EP1599189A4/fr not_active Withdrawn
- 2003-03-04 CA CA002518442A patent/CA2518442A1/fr not_active Abandoned
- 2003-03-04 JP JP2004569167A patent/JP2006514672A/ja active Pending
- 2003-03-04 WO PCT/US2003/006505 patent/WO2004078164A1/fr not_active Ceased
- 2003-03-04 NZ NZ542176A patent/NZ542176A/en unknown
- 2003-03-04 MX MXPA05009469A patent/MXPA05009469A/es unknown

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3343253A1 (de) *	1983-08-11	1985-02-21	Neill Bailey San Antonio Tex. Walsdorf	Fluorid-tablette mit verzoegerter wirkstoff-freigabe und verfahren zu ihrer herstellung
WO1997032584A1 (fr) *	1996-03-04	1997-09-12	Synthelabo	Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine
US6033685A (en) *	1997-01-10	2000-03-07	Abbott Laboratories	Tablet for the controlled release of active agents
WO2000001416A1 (fr) *	1998-07-07	2000-01-13	Yissum Research Developing Company Of The Hebrew University Of Jerusalem	Compositions pharmaceutiques contenant des cires a bas point de fusion

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DAKKURI-A. BUTLER-L-D. DELUCA-P-P.: "Sustained release from inert wax matrixes III: effect of povidone on tripelennamine hydrochloride release", JOURNAL OR PHARMACEUTICAL SCIENCES, vol. 67, no. 3, 1978, pages 357 - 360, XP009117092 *
See also references of WO2004078164A1 *

Also Published As

Publication number	Publication date
BR0318167A (pt)	2006-02-21
EP1599189A1 (fr)	2005-11-30
CA2518442A1 (fr)	2004-09-16
JP2006514672A (ja)	2006-05-11
NZ542176A (en)	2007-12-21
AU2003225649A1 (en)	2004-09-28
AU2003225649B2 (en)	2009-03-12
AU2003225649C1 (en)	2009-10-22
MXPA05009469A (es)	2005-12-12
WO2004078164A1 (fr)	2004-09-16

Legal Events

Date	Code	Title	Description
2005-10-14	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2005-11-30	17P	Request for examination filed	Effective date: 20050905
2005-11-30	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
2005-11-30	AX	Request for extension of the european patent	Extension state: AL LT LV MK
2006-06-07	DAX	Request for extension of the european patent (deleted)
2009-07-01	A4	Supplementary search report drawn up and despatched	Effective date: 20090602
2009-07-01	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 31/19 20060101ALI20090526BHEP Ipc: A61K 31/52 20060101ALI20090526BHEP Ipc: A61K 31/7048 20060101ALI20090526BHEP Ipc: A61K 33/26 20060101ALI20090526BHEP Ipc: A61K 9/22 20060101AFI20040922BHEP
2009-12-23	17Q	First examination report despatched	Effective date: 20091119
2012-02-24	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2012-03-28	18D	Application deemed to be withdrawn	Effective date: 20111001

Publication	Publication Date	Title
IL159048A0 (en)	2004-05-12	Sustained release formulation
SI1553929T1 (sl)	2013-07-31	Pripravek z nadzorovanim sproĹˇÄŤanjem
AU2003301516A8 (en)	2004-05-13	Antifungal formulations
EP1669193A4 (fr)	2010-07-21	Materiau de decoration
IL165349A0 (en)	2006-01-15	Microcapsule formulations
AU2003276710A8 (en)	2004-05-25	Deodorant composition
GB2397021B (en)	2006-09-13	Insecticidal paint composition
GB0311448D0 (en)	2003-06-25	Absorbent material
PL376840A1 (pl)	2006-01-09	Kompozycja farmaceutyczna o przedłużonym uwalnianiu
GB2399523B (en)	2005-11-23	Material supply system
GB0405760D0 (en)	2004-04-21	Agrochemical formulation
IL165069A0 (en)	2005-12-18	Immediate release pharmaceutical formulation
GB0328530D0 (en)	2004-01-14	Agrochemical composition
GB0305679D0 (en)	2003-04-16	Agrochemical formulation
EP1599189A4 (fr)	2009-07-01	Formulation a liberation commandee renfermant une substance hydrophobe comme agent de liberation soutenue
EP1599407A4 (fr)	2010-12-08	Palan pour materiau de construction
GB0328528D0 (en)	2004-01-14	Agrochemical composition
AU2003264519A1 (en)	2004-11-01	Deodorant agent
GB0328529D0 (en)	2004-01-14	Agrochemical composition
IL154920A0 (en)	2003-10-31	Delta 1-pyrrollines for use as pesticides
GB0327825D0 (en)	2003-12-31	Anti-reflection material
GB0320836D0 (en)	2003-10-08	Material
GB0227919D0 (en)	2003-01-08	Insecticidal agent
GB0311354D0 (en)	2003-06-25	Controlled release formulations
GB0305039D0 (en)	2003-04-09	Agrochemical formulation